The trading price of 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) closed higher on Monday, February 10, and closing at $0.61, 9.31% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.531 and $0.65. In examining the 52-week price action we see that the stock hit a 52-week high of $7.20 and a 52-week low of $0.45. Over the past month, the stock has lost -44.43% in value.
60 Degrees Pharmaceuticals Inc, whose market valuation is $4.46 million at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.65 per share this quarter, however they have predicted annual earnings per share of -5.68 for current year and -2.71 for next year.
Analysts have forecast the company to bring in revenue of 234k for the current quarter, with the likely lows of 200k and highs of 268k. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 622.5k.
On the technical side, indicators suggest SXTP has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned SXTP a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged 60 Degrees Pharmaceuticals Inc (SXTP) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that SXTP’s price is currently -21.80% off the SMA20 and -44.95% off the SMA50. The RSI metric on the 14-day chart is currently showing 38.60, and weekly volatility stands at 22.10%. When measured over the past 30 days, the indicator reaches 17.37%. 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s beta value is currently sitting at 4.27, while the Average True Range indicator is currently displaying 0.15.
To see how 60 Degrees Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: SXTP stock’s performance was 9.31% in the latest trading, and -81.87% in the past year.
An evaluation of the daily trading volume of 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) indicates that the 3-month average is 2.37 million. However, this figure has increased over the past 10 days to an average of 11.0.
Currently, records show that 1.86 million of the company’s shares remain outstanding. The insiders hold 32.48% of outstanding shares, whereas institutions hold 10.01%. The stats also highlight that short interest as of 2024-10-31, stood at 37296.0 shares, resulting in a short ratio of 0.34 at that time. From this, we can conclude that short interest is 212.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were up slightly from the previous month’s figure, which was 31301.0. However, since the stock’s price has seen -53.05% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
